Wall Street Zen Downgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Buy

Wall Street Zen Downgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Buy

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Monday. Other analysts have also issued research reports about the stock. Raymond James Financial reiterated a “strong-buy” rating on shares of Mirum Pharmaceuticals in a research note on Thursday, August 7th. Stifel Nicolaus set a $89.00 price objective on shar…